Back to resultsHigh Dose Nimodipine Treatment Adjunct - 1
Primary Purpose
Cocaine-Related Disorders
Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Nimodipine
Sponsored by
About this trial
This is an interventional treatment trial for Cocaine-Related Disorders
Eligibility Criteria
Please contact site for information.
Sites / Locations
- Washington DC VA
Outcomes
Primary Outcome Measures
Stimulated and non-stimulated craving
Stimulated and non-stimulated withdrawal
Anxiety, depression
Heart rate
Secondary Outcome Measures
Full Information
NCT ID
NCT00000332
First Posted
September 20, 1999
Last Updated
February 23, 2017
Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
Washington D.C. Veterans Affairs Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT00000332
Brief Title
High Dose Nimodipine Treatment Adjunct - 1
Official Title
High Dose Nimodipine Pharmacotherapy Adjunct
Study Type
Interventional
2. Study Status
Record Verification Date
December 2002
Overall Recruitment Status
Completed
Study Start Date
May 1998 (Actual)
Primary Completion Date
January 2000 (Actual)
Study Completion Date
April 2000 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
Washington D.C. Veterans Affairs Medical Center
4. Oversight
Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The purpose of this study is to determine if nimodipine is more effective than placebo in reducing stimulated craving for cocaine in cocaine dependent individuals denied access to cocaine in inpatient unit.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cocaine-Related Disorders
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Enrollment
0 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Nimodipine
Primary Outcome Measure Information:
Title
Stimulated and non-stimulated craving
Title
Stimulated and non-stimulated withdrawal
Title
Anxiety, depression
Title
Heart rate
10. Eligibility
Sex
All
Minimum Age & Unit of Time
22 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Please contact site for information.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Steven Deutsch, M.D.
Organizational Affiliation
Washington D.C. Veterans Affairs Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Washington DC VA
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20422
Country
United States
12. IPD Sharing Statement
Learn more about this trial
High Dose Nimodipine Treatment Adjunct - 1
We'll reach out to this number within 24 hrs